NCT03627728 Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer Status COMPLETED Phase PHASE2
NCT03621982 Study of ADCT-301 in Patients With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03620643 Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours Status COMPLETED Phase PHASE2
NCT03619681 Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer Status COMPLETED Phase PHASE1
NCT03613142 Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy Status UNKNOWN Phase NA
NCT03609892 Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy Status COMPLETED Phase PHASE4
NCT03601988 Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer Status UNKNOWN Phase PHASE3
NCT03598348 Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer Status UNKNOWN Phase PHASE3
NCT03597581 A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer Status COMPLETED Phase PHASE1
NCT03576131 GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT03575637 Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT03568110 Frailty and Postoperative Outcomes After Gastric Cancer Surgery Status COMPLETED Phase N/A
NCT03556345 A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2 Status COMPLETED Phase PHASE2
NCT03551951 Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow Status RECRUITING Phase N/A
NCT03539822 Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT03528629 A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma Status COMPLETED Phase NA
NCT03526835 A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT03525392 Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. Status TERMINATED Phase PHASE1